Patient-controlled Analgesia with Remifentanil in a Parturient with Ankylosing Spondylitis and SARS-CoV-2 Infection: A Case Report

Authors

  • Dominic D. Villa, MD Department of Anesthesiology, College of Medicine and Philippine General Hospital, University of the Philippines Manila
  • Christine Grace A. Suarez, MD Department of Anesthesiology, College of Medicine and Philippine General Hospital, University of the Philippines Manila
  • Jeffrey Paolo M. Nuñez, MD Department of Anesthesiology, College of Medicine and Philippine General Hospital, University of the Philippines Manila

DOI:

https://doi.org/10.47895/amp.v58i9.8779

Keywords:

ankylosing spondylitis, remifentanil, patient-controlled analgesia, obstetric analgesia, COVID-19

Abstract

Parturients with both ankylosing spondylitis (AS) and SARS-CoV-2 Infection (COVID-19) present unique challenges to anesthesiologists. Neuraxial analgesia for labor remains the gold standard in obstetric patients. However, in patients with AS, this approach may be deemed difficult to impossible. Administration of systemic opioids for labor analgesia can be an option, bearing in mind the potential respiratory depressant effect to both the mother and the fetus, especially in the setting of concomitant COVID-19. This paper reports the successful management of such a patient using patient-controlled analgesia (PCA) with intravenous remifentanil.

Downloads

Published

2024-05-23

Issue

Vol. 58 No. 9 (2024): Anesthesiology Issue 2

Section

Articles

How to Cite

1.
Patient-controlled Analgesia with Remifentanil in a Parturient with Ankylosing Spondylitis and SARS-CoV-2 Infection: A Case Report. Acta Med Philipp [Internet]. 2024 May 23 [cited 2025 Apr. 27];58(9). Available from: https://actamedicaphilippina.upm.edu.ph/index.php/acta/article/view/8779